DermTech, Inc. Skyrocketed
Tue, Jul 19, 2022 at 07:09 PM
DermTech, Inc. (DMTK:NASDAQ) soared at $7.61, a gain of 20.4%. On Tue, Jul 19, 2022, DMTK:NASDAQ touched a New 2-Week High of $7.61. The stock appeared on our News Catalysts scanner on Sun, Jul 03, 2022 at 11:16 AM in the 'INVESTOR UPDATE' category. From Tue, Jul 05, 2022, the stock recorded 60.00% Up Days and 45.45% Green Days
About DermTech, Inc. (DMTK:NASDAQ)
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
Top 10 Gainers:
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 45.31%
- Sidus Space Inc. (SIDU:NASDAQ), 40.64%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 32.17%
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 27.4%
- Power REIT (PW:NYSEMKT), 26.86%
- Verve Therapeutics Inc. (VERV:NASDAQ), 22.73%
- Fuwei Films (Holdings) Co., Ltd. (FFHL:NASDAQ), 22.59%
- Silvergate Capital Corporation (SI:NYSE), 22.37%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 20.63%
- DermTech, Inc. (DMTK:NASDAQ), 20.41%